Corrigendum to “APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis” [Atherosclerosis 240/1 (2015) 98–104]

Corrigendum to “APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis” [Atherosclerosis 240/1 (2015) 98e104] Montse Guardiola a, , Montserrat Cof an c, , Isabel de Castro-Or os , Ana Cenarro , Nuria Plana a, , Philippa J. Talmud , Lluis Masana a, , Emilio Ros c, , Fernando Civeira , Josep Ribalta a, b, * a Unitat de Recerca en Lipids i Arteriosclerosi, Hospital Universitari Sant Joan de Reus, Institut du0027Investigacions Sanit aries Pere Virgili, Universitat Rovira i Virgili, Reus, Spain b CIBER Diabetes y Enfermedades Metab olicas (CIBERdem), Instituto de Salud Carlos III (ISCIII), Spain c Lipid Clinic, Endocrinology u0026 Nutrition Service, Institut du0027Investigacions Biom ediques August Pi Sunyer, Hospital Clinic, Barcelona, Spain d CIBER Fisiopatologia de la Obesidad y Nutrici on (CIBERobn), ISCIII, Spain e Hospital Universitario Miguel Servet, Investigaci on Sanitaria de Arag on, Zaragoza, Spain f Centre of Cardiovascular Genetics, Institute of Cardiovascular Science, University College London, London, United Kingdom